Gene context drift identifies drug targets to mitigate cancer treatment resistance
Cancer Cell · 2025-09 · 43 (9) · 1608-1621.e9
DOI: 10.1016/j.ccell.2025.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-09. Verfasst von Amir Jassim und 29 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Electronic address: amir.ja…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Cancer Research UK, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Electronic address: amir.jassim@cruk.cam.ac.uk.
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethseda, MD 20892,…
- UK Dementia Research Institute at the University of Cambridge and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, UK; Department of Molecular Neuroscience,…
- Department of Radiotherapy, Beijing Tiantan Hospital Capital Medical University, Beijing 100070, China.
- Department of Pediatric Neurosurgery, Beijing Tiantan Hospital Capital Medical University, Beijing 100070, China.
Förderung
- NINDS NIH HHS
- Cancer Research UK
- NIGMS NIH HHS
- UK Dementia Research Institute
- Alex's Lemonade Stand Foundation for Childhood Cancer
- Brain Tumor Charity
- Glenn Foundation for Medical Research
- National Institutes of Health
Zitieren
APA
Jassim, A., Nimmervoll, B. V., Terranova, S., Nathan, E., Hu, L., Taylor, J. T., Masih, K. E., Ruff, L., Duarte, M., Cooper, E., Katyal, G., Akhbari, M., Gilbertson, R. J., Coleman, J. C., Toker, J. S., Terhune, C., Balmus, G., Jackson, S. P., Liu, H., …, & Gilbertson, R. J. (2025). Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer Cell, 43(9), 1608-1621.e9. https://doi.org/10.1016/j.ccell.2025.06.005
Vancouver
Jassim A, Nimmervoll BV, Terranova S, Nathan E, Hu L, Taylor JT, et al. Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer Cell. 2025;43(9):1608-1621.e9. doi:10.1016/j.ccell.2025.06.005
BibTeX
@article{Jassim2025,
author = {Jassim, Amir and Nimmervoll, Birgit V and Terranova, Sabrina and Nathan, Erica and Hu, Linda and Taylor, Jessica T and Masih, Katherine E and Ruff, Lisa and Duarte, Matilde and Cooper, Elizabeth and Katyal, Gunjan and Akhbari, Melika and Gilbertson, Reuben J and Coleman, Jennifer C and Toker, Joseph S and Terhune, Colton and Balmus, Gabriel and Jackson, Stephen P and Liu, Hailong and Jiang, Tao and Taylor, Michael D and Hua, Kui and Abraham, Jean E and Filbin, Mariella G and Hill, Anthony and Patrizi, Anarita and Dani, Neil and Regev, Aviv and Lehtinen, Maria K and Gilbertson, Richard J},
title = {Gene context drift identifies drug targets to mitigate cancer treatment resistance},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {9},
pages = {1608--1621.e9},
doi = {10.1016/j.ccell.2025.06.005}
}
EUVIMED